Skip to main content
All lobbying filings

DIALYSIS PATIENT CITIZENS

Lobbying for DIALYSIS PATIENT CITIZENS

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Expenses
$500,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 6
  • Centers For Medicare and Medicaid Services (CMS)
  • Health & Human Services, Dept of (HHS)
  • Health Resources & Services Administration (HRSA)
  • HOUSE OF REPRESENTATIVES
  • SENATE
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 6
  • S 1552
    Living Donor Protection Act of 2025
  • HR 4582
    To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surge…
  • HR 2199
    Restore Protections for Dialysis Patients Act
  • S 1173
    Restore Protections for Dialysis Patients Act
  • S 2730
    Kidney Care Access Protection Act
  • HR 6214
    Kidney Care Access Protection Act
 Lobbying activity 1
Medicare/Medicaid

Urge Congress to provide access to Medigap for all ESRD patients under 65 years of age; Protect organ donors by urging passage of the living donor legislation, including S. 1552/H.R. 4582/3 - The Living Donor Protection Act; Protect dialysis patient access to charitable premium assistance; Support ESRD care coordination; Support increased oversight of Organ Procurement Organizations; Assist the Administration about prioritizing prevention of kidney disease and home dialysis; Support H.R. 2199/S. 1173 -The Restore Protections for Dialysis Patients Act to protect access to private insurance; and Support S. 2730/H.R. 6214 - The Kidney Care Access Protection Act which would ensure appropriate reimbursement for quality care and improve patient access to innovative drugs, treatments, and technologies. Encourage Members of Congress to join the Congressional Kidney Caucus

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem